Obermatt
See Similar Stocks →

Dogwood Therapeutics

NAQ:DWTX · US92829J2033
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings27
Price/Book76
Dividend Yield—
Revenue Growth—
Profit Growth21
Capital Growth73
TSR 52w4
Leverage93
Liquidity97
Refinancing55
Combined—
Analyst Opinions23
Pro Holdings5
Opinion Changes50
Market Pulse8

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded2020
Employees10
Websitedwtx.com
ISINUS92829J2033
Last UpdateApr 2, 2026
Index & Theme
Pain ManagementInfectious DiseasesNeuroscienceOncologyNeurologyChronic DiseasesCentral Nervous SystemBiotechnologyHealth CareMobile AppsTherapeutics

Description

Dogwood Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing new medicines to treat pain and fatigue-related disorders. The company’s pipeline is focused on two separate pillars: Na v 1.7 modulation to treat chron…

Similar Stocks

The companies this stock is ranked against.

Compare Dogwood Therapeutics with its peers
Atossa Therapeutics
NAQ:ATOS
45
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Mineralys Therapeutics
NSQ:MLYS
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Regenxbio
NSQ:RGNX
17
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Foghorn Therapeutics
NMQ:FHTX
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Beyondspring
NAQ:BYSI
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Acrivon Therapeutics
NMQ:ACRV
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →